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Research Round Up- Opioid Drugs: A high risk prescribing area? 
Introduction 
The last research round up provided an overview of research, information, and guidelines around 
the involvement of the healthcare professional in the COVID-19 pandemic.  
This month we will evaluate some recent research around prescribing opioid medications across 
various settings.  
There has been concern over prescribing of opioids and the high risk of harm associated with their 
use for many years now. This is an area of active research and controversial opinions which has 
attracted much public and media attention. There are many emerging studies looking at how, why 
and how long opioids are prescribed.  In this round up we will look at four different aspects of opioid 
prescribing practices in the UK that have had publications around them in the last few months. 
 
Prescribing High Dose Opioids in Primary Care 
The authors start this paper by looking at the current picture of prescribing of opioids in a primary 
care setting. They acknowledge that research shows that an increase in opioid prescribing for long-
term pain conditions has led to more people taking opioids and taking these at higher doses that has 
been seen before. Supporting literature presented here reveals that high doses of opioids are 
associated with greater morbidity, mortality, and cost. Despite this, the prescribing of high-dose 
opioids remains relatively common in high-income countries. The authors, to investigate the 
phenomenon, conducted a systematic review of observational studies into opioid use in high income 
countries up to and including April 2019. Searching and quality appraisal of articles led to inclusion of 
6 studies form the USA, Australia and the UK. These papers presented information on over 4million 
opioid users. They reported findings in the form of factors commonly associated with high dose 
opioid prescription in primary care. These ranged from concurrent prescription of benzodiazepines, 
depressive symptoms, increased visits to accident and emergency departments, unemployment and 
being male. All these factors came out as significant in the literature included. They conclude that 
patients prescribed high doses of opioids have a greater risk of harm. They identify key factors such 
as the co-prescription of benzodiazepines and the presence of depressive symptoms as a priority for 
consideration when managing people on high-dose opioids in primary care. They recommend that 
coordinated approaches to promote and monitor prescribing are necessary for safe prescribing 
practice. 
Georgia C. Richards, Kamal R. Mahtani, Tonny B. Muthee, Nicholas J. DeVito1, Constantinos Koshiari , 
Jeffrey K. Aronson , Ben Goldacre and Carl J. Heneghan (2020) Factors associated with the 
prescribing of high-dose opioids in primary care: a systematic review and meta-analysis. BMC 
Medicine 18:68 Retrieved from https://link.springer.com/content/pdf/10.1186/s12916-020-01528-
7.pdf 
 
Co-prescribing of Opioids with Gabapentinoids 
Recent advances in the understanding and study of gabapentinoids in pain have led to an increase in 
their prescribing adjunct to or instead of opioid prescribing. There have been concerns around 
concomitant prescribing of these drugs and the potential for increased harm. This study sought to 
investigate national and regional prescribing rates and patterns over the period 2006–2016 and to 
try to identify if there were any associated factors. Outcomes investigated were age, gender, 
sociodemographic data and co-prescription. Morbidity and mortality were assessed as were the 
incidence of drug related deaths after access to relevant and accessible database information. 
Findings proved enlightening in many areas. Firstly the increase in prescribing gabapentin in Scotland 
over that 10 year period is 4 fold whereas prescribing of pregabalin has increased 16 fold.  Mean age 
for those receiving repeated prescriptions of gabapentinoids was reported as 58.1 years and 62.5% 
were female and had a higher chance of living in what were described as deprived areas. Related to 
this, 60% of this population were co-prescribed the gabapentinoid with either an opioid, a 
benzodiazepine of both. They also discovered that the age-standardised death rate in those who 
were prescribed in this instance was double the national average among the Scottish population. 
Worryingly some of the deaths due to concomitant use were seen in those for whom some of the 
combination of the drugs had not been prescribed but obtained via other routes. They conclude that 
concomitant use of gabapentinoids with benzodiazepines and/or opioids represents a potentially 
dangerous combination. They suggest that the contribution of this concomitant use to an increase in 
drug related deaths may be more related to illegal use and diversion rather than poor prescribing 
practice.  
Nicola Torrance,Abirami Veluchamy,Yiling Zhou,Emma H. Fletcher,Eilidh Moir,Harry L. Hebert,Peter 
T. Donnan,Jennifer Watson,Lesley A. Colvin,Blair H. Smith(2020) Trends in gabapentinoid prescribing, 
co-prescribing of opioids and benzodiazepines, and associated deaths in Scotland. British Journal of 
Anaesthesia,  
Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S0007091220303731 
 
Opioid Substitution Prescribing in Substance Misuse 
This mixed methods analysis of patient safety data aimed to gain an overview of incidents involving 
opioid substitution treatment. Its focus was on those prescribed either buprenorphine as a 
substitute for illegal or high dose opioids or methadone in a community setting. The outcome 
measure was harm (source and nature). The authors sought to identify themes that could be present 
which may lead to the elucidation of priority areas for service improvement.  
The authors examined data from 2005-2015 which they obtained from the National Reporting & 
Learning System in England and Wales and identified 2284 reports of safety issues in patients 
prescribed opioid substitution therapy in a community setting. They identified that most cases of 
harm occurred if there was a failure in the delivery of care in 4 discreet areas: Prescribing, 
supervised dispensing, non-supervised dispensing and monitoring. Prescribing related incidents 
included wrong doses, incorrect strength, incomplete or incorrect prescriptions and contraindicated 
drugs. Monitoring incidents centred around poor record keeping and communication failures. 
Analysis of the reports revealed that most of the incidents of harm resulted from the 2 dispensing 
areas. They were able to subcategorise the incidents into two further themes; Staff related and 
organisational. Staff related incidents were identified as slip ups during the dispensing task or not 
following defined protocols. Organisational issues included poor working conditions and breaks in 
the continuity of care. Several other contributory factors were also identified suggesting failures in 
dispensing was multifactorial. The authors recommend that health care providers strengthen 
processes to mitigate against harm caused by unsafe opioid substitution. They suggest that 
prescribing education, the use of electronic prescribing, implementation of dispensing monitoring 
systems and procedural and educational interventions for pharmacy staff could reduce the incidence 
of reportable safety issues.  
Gibson, R., MacLeod, N., Donaldson, L. J., Williams, H., Hibbert, P., Parry, G., Bhatt, J., Sheikh, A., 
and Carson‐Stevens, A. ( 2020) A mixed‐methods analysis of patient safety incidents involving opioid 
substitution treatment with methadone or buprenorphine in community‐based care in England and 





The Effect of an Opioid Review Clinic in a Primary Care Setting  
This mixed methods evaluation of an opioid review clinic focusses on two General Practices in 
England and aimed to determine the impact of the service on opioid use, health and wellbeing 
outcomes and quality of life. The evaluation of the clinic took place over a period of 15 months. 
Patients referred to the review clinic had to have had a minimum of 3 opioid prescriptions in the 
three months immediately prior to referral. Participants in the service were interviewed and also 
completed questionnaires to allow the researchers to gather appropriate data and views from the 
service users. Data such as demographic information, opioid use, misuse and dosing, health and 
wellbeing, quality of life measures and pain scores were collected. Service providers were also 
interviewed to explore their experiences of and views on the impact of the clinic. Findings revealed 
that the median prescribed dose reduced over time from 90mg at baseline to 72mg at follow up, 
achieving statistical significance. Some service users managed to be weaned off their opioids 
completely. In general the attendees at the clinic achieved an improvement in their scores on the 
health and wellbeing and quality of life scores reporting increase confidence and self-esteem, ability 
to employ pain management strategies and reduced doses of medication required. The clinic was 
very well received by both service users and providers suggesting the benefit of such a service. 
Recommendations were that following further service development a randomised control trial could 
be conducted to establish more robust data to inform future service provision.  
Lauren J Scott, Joanna M Kesten, Kevin Bache, Matthew Hickman, Rona Campbell, Anthony E 
Pickering, Sabi Redwood, Kyla Thomas (2020) Evaluation of a primary care-based opioid and pain 
review service: a mixed-methods evaluation in two GP practices in England. British Journal of 




Opioid prescribing, whether alone or in combination can be considered a high-risk prescribing 
activity. Protocols and procedures should be in place and adhered to in order to minimise the risk of 
harm in all aspects of opioid prescribing. Central to safer prescribing and use are good education 
around opioid use, patient centred management, regular monitoring and review and good 
communication. 
